AU
UK
CA
NZ
IND
US
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted marketing and manufacturing authorization for Dupixent® (dupilumab) to treat chronic obstructive pulmonary disease (COPD) in adults whose condition is not well-managed with existing therapies. This …
Pony.ai (NASDAQ: PONY) achieved a significant milestone on March 27, 2025, as the first company authorized to operate paid fully-driverless robotaxi services in Shenzhen's Nanshan District. This marks a key moment in the city's progress toward offering autonomous ride-hailing services in its urban centers.
Index Update
Yiren Digital partners with AG Networkto develop AI-powered financial solutions for Indonesia.
Lacutamab granted FDA Breakthrough Therapy Designationfor relapsed or refractory Sézary syndrome.
€130 Million Investment:Alpha Bio will establish a commercial-scale biopolymer production facility in Finland.
28% reduction in operating expenses, down to$9.9 millionfrom$13.8 millionin 2023.
Index Update
Hoth Therapeutics, Inc. (NASDAQ: HOTH) has announced significant progress in the development of its proprietary antisense oligonucleotide (ASO) drug candidate, HT-KIT. The biopharmaceutical company is focused on creating therapies for allergic and inflammatory diseases, and HT-KIT represents an innovative approach to treating conditions such …
V2X Inc. (NYSE: VVX) has been selected as a winner for the Bridge to Enduring Synthetic Training Environment Tactical Engagement Simulation Systems (TESS) Multiple-Award Contract (BEST MAC) Lot 1. This contract is a key component of the U.S. Army’s live training capabilities, as it …
Please wait processing your request...